• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma".

作者信息

Granata Vincenza, Fusco Roberta, Palaia Raffaele, Belli Andrea, Petrillo Antonella, Izzo Francesco

机构信息

Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Naples, Italy.

出版信息

Ann Surg Oncol. 2020 Dec;27(Suppl 3):954-955. doi: 10.1245/s10434-020-09183-1. Epub 2020 Oct 4.

DOI:10.1245/s10434-020-09183-1
PMID:33011913
Abstract
摘要

相似文献

1
Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma".对《不可逆电穿孔联合FOLFIRINOX进行电化学疗法可提高胰腺腺癌小鼠模型的生存率》的评论
Ann Surg Oncol. 2020 Dec;27(Suppl 3):954-955. doi: 10.1245/s10434-020-09183-1. Epub 2020 Oct 4.
2
Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma.电化学治疗联合不可逆电穿孔和 FOLFIRINOX 方案改善胰腺腺癌细胞株模型的生存。
Ann Surg Oncol. 2020 Oct;27(11):4348-4359. doi: 10.1245/s10434-020-08782-2. Epub 2020 Jul 17.
3
Comment: Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.评论：CT引导下经皮不可逆电穿孔联合FOLFIRINOX化疗在局部晚期胰腺癌中的价值：一项事后比较
J Vasc Interv Radiol. 2021 May;32(5):765-766. doi: 10.1016/j.jvir.2020.11.025. Epub 2021 Feb 26.
4
CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.新辅助FOLFIRINOX化疗后对交界性和局部晚期胰腺腺癌的CT评估。
Eur Radiol. 2017 Jul;27(7):3104-3116. doi: 10.1007/s00330-016-4632-8. Epub 2016 Nov 28.
5
FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?FOLFIRINOX或FOLFOXIRI方案用于局部晚期十二指肠腺癌：我们是否有所遗漏？
ESMO Open. 2020 Oct;5(5):e000633. doi: 10.1136/esmoopen-2019-000633.
6
Port-site metastasis of pancreatic adenocarcinoma following 'successful' completion of neoadjuvant chemoradiation using FOLFIRINOX.使用FOLFIRINOX方案完成新辅助放化疗“成功”后发生的胰腺腺癌切口转移
ANZ J Surg. 2020 May;90(5):922-924. doi: 10.1111/ans.15441. Epub 2019 Oct 2.
7
Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.UGT1A1 基因多态性对不可切除胰腺癌患者接受 FOLFIRINOX 治疗的毒性影响。
Cancer Sci. 2019 Feb;110(2):707-716. doi: 10.1111/cas.13883. Epub 2018 Dec 12.
8
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.首创新药 CPI-613 联合改良 FOLFIRINOX 方案治疗转移性胰腺癌患者的安全性和耐受性：一项单中心、开放标签、剂量递增、I 期临床试验。
Lancet Oncol. 2017 Jun;18(6):770-778. doi: 10.1016/S1470-2045(17)30314-5. Epub 2017 May 8.
9
Meta-analysis of Modified FOLFIRINOX Regimens for Patients With Metastatic Pancreatic Cancer.转移性胰腺癌改良 FOLFIRINOX 方案的荟萃分析。
Clin Colorectal Cancer. 2018 Sep;17(3):187-197. doi: 10.1016/j.clcc.2018.03.007. Epub 2018 Mar 14.
10
FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.FOLFIRINOX 方案治疗局部进展期胰腺癌：来自日本全国多中心观察性研究的亚组分析结果和预后因素。
Pancreatology. 2019 Mar;19(2):296-301. doi: 10.1016/j.pan.2019.01.001. Epub 2019 Jan 4.

引用本文的文献

1
Treatments and cancer: implications for radiologists.治疗与癌症：对放射科医生的影响
Front Immunol. 2025 Apr 16;16:1564909. doi: 10.3389/fimmu.2025.1564909. eCollection 2025.
2
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.风险评估与胰腺癌：诊断管理与人工智能
Cancers (Basel). 2023 Jan 5;15(2):351. doi: 10.3390/cancers15020351.
3
Local ablation of pancreatic tumors: State of the art and future perspectives.胰腺肿瘤的局部消融治疗：现状与未来展望。
World J Gastroenterol. 2021 Jun 21;27(23):3413-3428. doi: 10.3748/wjg.v27.i23.3413.
4
A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response.关于用于检测和评估基于电穿孔治疗反应的影像学和组织病理学发现的系统评价。
Int J Environ Res Public Health. 2021 May 24;18(11):5592. doi: 10.3390/ijerph18115592.
5
Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge.胰腺癌消融治疗的评估：放射科医生面临的挑战。
Front Oncol. 2020 Nov 27;10:560952. doi: 10.3389/fonc.2020.560952. eCollection 2020.